Valuation: Septerna, Inc.

Market Cap 150.96Cr 132.71Cr 123.53Cr 113.45Cr 213.03Cr 14TCr 215.84Cr 1.47TCr 573.49Cr 7.15TCr 566.68Cr 554.47Cr 25TCr P/E 2026 *
-19.4x
P/E 2027 * -13.8x
Enterprise Value 116.07Cr 102.04Cr 95Cr 87Cr 163.79Cr 11TCr 165.95Cr 1.13TCr 440.94Cr 5.5TCr 435.71Cr 426.32Cr 19TCr EV / Sales 2026 *
15.1x
EV / Sales 2027 * 15.2x
Free-Float
97.17%
Yield 2026 *
-
Yield 2027 * -
1 day-1.52%
1 week+0.12%
Current month+0.69%
1 month-2.96%
3 months+38.82%
6 months+42.52%
Current year+20.95%
1 week 32.48
Extreme 32.475
34.97
1 month 30.55
Extreme 30.55
38.04
Current year 22.78
Extreme 22.78
38.04
1 year 10.62
Extreme 10.6161
38.04
3 years 4.17
Extreme 4.17
38.04
5 years 4.17
Extreme 4.17
38.04
10 years 4.17
Extreme 4.17
38.04
Manager TitleAgeSince
Chief Executive Officer 60 01/11/2021
Director of Finance/CFO 55 06/01/2025
President 58 01/08/2025
Director TitleAgeSince
Director/Board Member 60 01/11/2021
Chairman 50 01/11/2021
Director/Board Member 41 01/11/2021
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Fiscal year

Chairperson

12,000 0.0266%
01/07/26 Fiscal year

Executive/Senior Manager

9,999 0.0222%
29/06/26 Fiscal year

Head of Human Resources

6,534 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%+0.12%+143.82% - 150.96Cr
+1.05%-0.25%-0.46%+11.49% 4.77TCr
-2.54%+2.07%+402.09%+627.65% 4TCr
+0.69%+2.71%+11.14%+45.39% 3.62TCr
+14.63%+20.60%+22.95%+7.52% 3.56TCr
+0.62%+3.53%+5.41%+42.19% 2.79TCr
-2.60%-1.61% - - 1.67TCr
+1.83%+12.34%+31.84%+134.40% 1.65TCr
+2.36%-1.72%+4.65%+9.85% 1.32TCr
+9.28%+10.29%-3.11%-27.12% 1.29TCr
Average +2.30%+2.89%+68.70%+106.42% 2.48TCr
Weighted average by Cap. +2.51%+2.94%+78.55%+133.56%

Financials

2026 *2027 *
Net sales 7.69Cr 6.76Cr 6.29Cr 5.78Cr 11Cr 737.6Cr 11Cr 75Cr 29Cr 364.21Cr 29Cr 28Cr 1.26TCr 6.58Cr 5.79Cr 5.39Cr 4.95Cr 9.29Cr 631.34Cr 9.41Cr 64Cr 25Cr 311.74Cr 25Cr 24Cr 1.08TCr
Net income -6.89Cr -6.05Cr -5.63Cr -5.17Cr -9.72Cr -660.32Cr -9.85Cr -67Cr -26Cr -326.06Cr -26Cr -25Cr -1.13TCr -12Cr -11Cr -10Cr -9.2Cr -17Cr -1.17TCr -18Cr -119.11Cr -47Cr -579.84Cr -46Cr -45Cr -2TCr
Net Debt -35Cr -31Cr -29Cr -26Cr -49Cr -3.35TCr -50Cr -339.38Cr -132.55Cr -1.65TCr -130.97Cr -128.15Cr -5.71TCr -51Cr -45Cr -42Cr -38Cr -72Cr -4.88TCr -73Cr -494.57Cr -193.16Cr -2.41TCr -190.87Cr -186.75Cr -8.32TCr
Logo Septerna, Inc.
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.
Employees
130
Date Price Change Volume
28/26/28 $33.39 -0.31% 5,158
27/26/27 $33.49 +1.18% 1,43,876
24/26/24 $33.10 -1.11% 2,42,035
23/26/23 $33.47 -2.13% 2,98,231
22/26/22 $34.20 +1.54% 2,64,140
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
33.49USD
Average target price
45.00USD
Spread / Average Target
+34.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEPN Stock